For the year ending 2025-12-31, MANE has $152,619K in assets. $9,156K in debts. $21,766K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 21,766 | |||
| Marketable securities at fair value | 120,096 | |||
| Prepaid expenses and other current assets | 10,632 | |||
| Total current assets | 152,494 | |||
| Property, plant and equipment, net | 22 | |||
| Right-of-use asset and other long-term assets | 103 | |||
| Total non-current assets | 125 | |||
| Total assets | 152,619 | |||
| Accounts payable | 2,126 | |||
| Accrued expenses | 6,979 | |||
| Other current liabilities and lease liabilities | 47 | |||
| Total current liabilities | 9,152 | |||
| Lease liabilities - non-current | 4 | |||
| Total liabilities | 9,156 | |||
| Redeemable convertible preferred stock-Series APreferred Stock | 36,860 | |||
| Redeemable convertible preferred stock-Series BPreferred Stock | 78,903 | |||
| Redeemable convertible preferred stock-Series CPreferred Stock | 150,563 | |||
| Subscription receivable | 1,849 | |||
| Common stock, 0.00001 par value, 98,774,582 and 25,500,000 authorized as of december 31, 2024 and 2023, respectively and 7,418,740 shares issued and outstanding | 1 | |||
| Additional paid-in capital | 2,346 | |||
| Accumulated other comprehensive income | 60 | |||
| Accumulated deficit | -123,421 | |||
| Total stockholders deficit | -121,014 | |||
| Total liabilities, redeemable convertible preferred stock, and stockholders deficit | 152,619 | |||
Veradermics, Inc (MANE)
Veradermics, Inc (MANE)